TORNIAI, MARIANGELA
 Distribuzione geografica
Continente #
NA - Nord America 1.548
EU - Europa 595
AS - Asia 293
AF - Africa 48
SA - Sud America 36
Totale 2.520
Nazione #
US - Stati Uniti d'America 1.547
IT - Italia 116
SG - Singapore 90
UA - Ucraina 88
RU - Federazione Russa 80
IE - Irlanda 78
SE - Svezia 75
CN - Cina 67
HK - Hong Kong 59
DE - Germania 50
TR - Turchia 41
BR - Brasile 35
CI - Costa d'Avorio 34
FI - Finlandia 30
DK - Danimarca 25
GB - Regno Unito 15
KR - Corea 15
BE - Belgio 14
MA - Marocco 12
FR - Francia 11
IN - India 10
ES - Italia 3
JP - Giappone 3
NL - Olanda 3
LT - Lituania 2
PL - Polonia 2
AR - Argentina 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
CZ - Repubblica Ceca 1
ID - Indonesia 1
IQ - Iraq 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
MN - Mongolia 1
PT - Portogallo 1
UZ - Uzbekistan 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 2.520
Città #
Chandler 218
Fairfield 139
Ashburn 135
Jacksonville 131
Des Moines 113
Dublin 78
Wilmington 73
Boardman 68
Hong Kong 59
Woodbridge 58
New York 57
Singapore 55
Seattle 54
Houston 51
Cambridge 49
Ann Arbor 37
Abidjan 34
Lawrence 31
Princeton 31
Turin 31
San Mateo 30
Los Angeles 16
Moscow 15
Washington 15
Brussels 14
San Diego 14
Helsinki 13
The Dalles 11
Centro 10
Falls Church 9
Pune 9
Shanghai 8
Beijing 7
Norwalk 7
Guangzhou 6
Kilburn 6
Ancona 5
Dallas 4
Jiaxing 3
London 3
Montegiorgio 3
Rio de Janeiro 3
Santa Clara 3
São Paulo 3
Turku 3
Wuxi 3
Campos dos Goytacazes 2
Castelraimondo 2
Chengdu 2
Cupra Marittima 2
Hounslow 2
Hyattsville 2
Munich 2
Porto 2
Shenzhen 2
Tokyo 2
Warsaw 2
Alfenas 1
Andrelândia 1
Ankara 1
Aversa 1
Baghdad 1
Baku 1
Belo Horizonte 1
Betim 1
Bevagna 1
Bishkek 1
Campina Grande 1
Cernusco sul Naviglio 1
Chennai 1
Chicago 1
Chiswick 1
Chizhou 1
Concórdia 1
Council Bluffs 1
Curvelo 1
Darling 1
Derventa 1
Devoto 1
Divinópolis 1
Engenheiro Caldas 1
Espírito Santo do Pinhal 1
Foligno 1
Friesland 1
Fuzhou 1
Gameleira 1
Genoa 1
Guarulhos 1
Harrison 1
Hengyang 1
Ho Chi Minh City 1
Hortolândia 1
Iporá 1
Istanbul 1
Jianning 1
Kingston 1
Lagoa Santa 1
Lanzhou 1
Lisbon 1
Marrakesh 1
Totale 1.790
Nome #
Electrolyte disorders in advanced non-small cell lung cancer patients treated with immune check-point inhibitors: a systematic review and meta-analysis 116
Prognostic relevance of programmed cell death protein 1/programmed death-ligand 1 pathway in thymic malignancies with combined immunohistochemical and biomolecular approach 103
Gastrointestinal neuroendocrine tumors: Searching the optimal treatment strategy-A literature review 98
Gender differences and outcome of melanoma patients 94
Electrolyte disorders in cancer patients: a systematic review 94
Benefits and limitations of a multidisciplinary approach in cancer patient management 93
Gender Differences and Outcomes in Melanoma Patients 92
Hyponatremia in cancer patients: Time for a new approach 91
Clinical and pathologic predictors of clinical outcome of malignant pleural mesothelioma 90
Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors 90
Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patients. 89
Hyponatraemia is a predictor of clinical outcome for malignant pleural mesothelioma 89
Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy 89
Risk of hyponatraemia in cancer patients treated with targeted therapies: A systematic review and meta-analysis of clinical trials 87
Systemic treatment for lung carcinoids: from bench to bedside 85
High CTLA-4 expression correlates with poor prognosis in thymoma patients 85
Pre-treatment systemic immune-inflammation represents a prognostic factor in patients with advanced non-small cell lung cancer 83
Hormonal receptors in lung adenocarcinoma: expression and difference in outcome by sex 81
Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms 80
Medical treatment for gastro-entero-pancreatic neuroendocrine tumours 79
Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy 79
Locally advanced rectal cancer: the importance of a multidisciplinary approach. 76
Gastro-entero-pancreatic neuroendocrine tumors: Is now time for a new approach? 76
Impact of phosphoinositide-3-kinase and vitamin D3 nuclear receptor single-nucleotide polymorphisms on the outcome of malignant melanoma patients 76
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50% 75
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues 73
Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: A multicenter retrospective analysis 71
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: An insight from clinical practice 71
Syndrome of inappropriate anti-diuretic hormone secretion in cancer patients: results of the first multicenter Italian study 60
Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians’ attitudes 56
Medical Treatment in Gastroenteropancreatic Neuroendocrine Neoplasms: a look into the future. 52
Targeted Genomic Profiling and Chemotherapy Outcomes in Grade 3 Gastro-Entero-Pancreatic Neuroendocrine Tumors (G3 GEP-NET) 14
Totale 2.587
Categoria #
all - tutte 14.986
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.986


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202064 0 0 0 0 0 0 0 0 0 0 18 46
2020/2021551 36 50 80 24 67 32 27 45 55 51 48 36
2021/2022246 16 36 14 3 7 30 11 12 28 24 25 40
2022/2023666 40 78 42 58 30 165 0 35 128 4 70 16
2023/2024360 51 6 31 22 48 107 7 25 1 15 1 46
2024/2025462 71 53 17 4 41 31 52 25 103 27 38 0
Totale 2.587